Many important cancer-related genes harbor these mutations, such as TP53, ATRX, BAP1, CTNNB1, RB1, etc. It is noteworthy that we found five SCMs in ATRX among 288 LGG cases, likely leading to the disruption of ATRX function. This evidence concerns the gene TP53 and cancer.